These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28185021)

  • 1. Patient-Initiated Repackaging of Antiretroviral Therapy, Viral Suppression and Drug Resistance.
    Ramadhani HO; Muiruri C; Maro VP; Nyombi B; Omondi M; Mushi JB; Lirhunde ES; Bartlett JA
    AIDS Behav; 2018 May; 22(5):1671-1678. PubMed ID: 28185021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health Care-Specific Enacted HIV-Related Stigma's Association with Antiretroviral Therapy Adherence and Viral Suppression Among People Living with HIV in Florida.
    Algarin AB; Sheehan DM; Varas-Diaz N; Fennie KP; Zhou Z; Spencer EC; Cook RL; Morano JP; Ibanez GE
    AIDS Patient Care STDS; 2020 Jul; 34(7):316-326. PubMed ID: 32639208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Socioeconomic factors explain suboptimal adherence to antiretroviral therapy among HIV-infected Australian adults with viral suppression.
    Siefried KJ; Mao L; Kerr S; Cysique LA; Gates TM; McAllister J; Maynard A; de Wit J; Carr A;
    PLoS One; 2017; 12(4):e0174613. PubMed ID: 28369066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strengthening HIV therapy and care in rural Tanzania affects rates of viral suppression.
    Ntamatungiro AJ; Muri L; Glass TR; Erb S; Battegay M; Furrer H; Hatz C; Tanner M; Felger I; Klimkait T; Letang E;
    J Antimicrob Chemother; 2017 Jul; 72(7):2069-2074. PubMed ID: 28387865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First line antiretroviral treatment failure and associated factors among people living with HIV in northwest Ethiopia.
    Genet A; Mekonnen Z; Yizengaw E; Mekonnen D
    Afr Health Sci; 2021 Mar; 21(1):263-272. PubMed ID: 34394306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy.
    Benning L; Mantsios A; Kerrigan D; Coleman JS; Golub E; Blackstock O; Konkle-Parker D; Philbin M; Sheth A; Adimora AA; Cohen MH; Seidman D; Milam J; Kassaye SG; Taylor T; Murray M
    BMC Womens Health; 2020 Jul; 20(1):152. PubMed ID: 32711509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cross-sectional study to evaluate second line virological failure and elevated bilirubin as a surrogate for adherence to atazanavir/ritonavir in two urban HIV clinics in Lilongwe, Malawi.
    Ongubo DM; Lim R; Tweya H; Stanley CC; Tembo P; Broadhurst R; Gugsa S; Ngongondo M; Speight C; Heller T; Phiri S; Hosseinipour MC
    BMC Infect Dis; 2017 Jul; 17(1):461. PubMed ID: 28673254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simple self-reported adherence tool as a predictor of viral rebound in people with viral suppression on antiretroviral therapy.
    O'Connor JL; Gardner EM; Esser S; Mannheimer SB; Lifson AR; Telzak EE; Phillips AN;
    HIV Med; 2016 Feb; 17(2):124-32. PubMed ID: 26186609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research on the treatment effects and drug resistances of long-term second-line antiretroviral therapy among HIV-infected patients from Henan Province in China.
    Chen J; Zhang M; Shang M; Yang W; Wang Z; Shang H
    BMC Infect Dis; 2018 Nov; 18(1):571. PubMed ID: 30442114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal antiretroviral therapy adherence as evaluated by CASE index score tool is associated with virological suppression in HIV-infected adults in Dakar, Senegal.
    Byabene AK; Fortes-Déguénonvo L; Niang K; Manga MN; Bulabula ANH; Nachega JB; Seydi M
    Trop Med Int Health; 2017 Jun; 22(6):776-782. PubMed ID: 28407436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved virological suppression in children on antiretroviral treatment receiving community-based adherence support: a multicentre cohort study from South Africa.
    Fatti G; Shaikh N; Eley B; Grimwood A
    AIDS Care; 2014 Apr; 26(4):448-53. PubMed ID: 24215157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Influencing Antiretroviral Adherence and Virological Outcomes in People Living with HIV in the Highlands of Papua New Guinea.
    Gare J; Kelly-Hanku A; Ryan CE; David M; Kaima P; Imara U; Lote N; Crowe SM; Hearps AC
    PLoS One; 2015; 10(8):e0134918. PubMed ID: 26244516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sociodemographic factors affecting viral load suppression among people living with HIV in South Carolina.
    Haider MR; Brown MJ; Harrison S; Yang X; Ingram L; Bhochhibhoya A; Hamilton A; Olatosi B; Li X
    AIDS Care; 2021 Mar; 33(3):290-298. PubMed ID: 31856584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants.
    Prendergast A; Mphatswe W; Tudor-Williams G; Rakgotho M; Pillay V; Thobakgale C; McCarthy N; Morris L; Walker BD; Goulder P
    AIDS; 2008 Jul; 22(11):1333-43. PubMed ID: 18580613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic and virological response to ART among HIV infected individuals at a tertiary hospital in Ghana.
    Obiri-Yeboah D; Pappoe F; Baidoo I; Arthur F; Hayfron-Benjamin A; Essien-Baidoo S; Kwakye-Nuako G; Ayisi Addo S
    BMC Infect Dis; 2018 May; 18(1):230. PubMed ID: 29783953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High viral suppression and low attrition in healthy HIV-infected patients initiated on ART with CD4 above 500 cells/µL in a program setting in Uganda.
    Byonanebye DM; Semitala FC; Katende J; Bakenga A; Arinaitwe I; Kyambadde P; Musinguzi P; Biraro IA; Byakika-Kibwika P; Kamya MR
    Afr Health Sci; 2020 Mar; 20(1):132-141. PubMed ID: 33402901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-level outcomes and virologic suppression rates in HIV-infected patients receiving antiretroviral therapy in Rwanda.
    Riedel DJ; Stafford KA; Memiah P; Coker M; Baribwira C; Sebeza J; Karorero E; Nsanzimana S; Morales F; Redfield RR
    Int J STD AIDS; 2018 Aug; 29(9):861-872. PubMed ID: 29621951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High turnaround times and low viral resuppression rates after reinforced adherence counselling following a confirmed virological failure diagnostic algorithm in HIV-infected patients on first-line antiretroviral therapy from Tanzania.
    Kroidl A; Burger T; Urio A; Mugeniwalwo R; Mgaya J; Mlagalila F; Hoelscher M; Däumer M; Salehe O; Sangare A; Lennemann T; Maganga L
    Trop Med Int Health; 2020 May; 25(5):579-589. PubMed ID: 31984634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to antiretroviral therapy among HIV infected children measured by caretaker report, medication return, and drug level in Dar Es Salaam, Tanzania.
    Mghamba FW; Minzi OM; Massawe A; Sasi P
    BMC Pediatr; 2013 Jun; 13():95. PubMed ID: 23768248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virological outcomes of antiretroviral therapy in Zomba central prison, Malawi; a cross-sectional study.
    Mpawa H; Kwekwesa A; Amberbir A; Garone D; Divala OH; Kawalazira G; van Schoor V; Ndindi H; van Oosterhout JJ
    J Int AIDS Soc; 2017 Aug; 20(1):21623. PubMed ID: 28782332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.